Exchange Traded Concepts’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.19M | Buy |
21,617
+1,821
| +9% | +$100K | 0.01% | 611 |
|
|
2025
Q1 | $1.4M | Buy |
19,796
+979
| +5% | +$69.2K | 0.02% | 455 |
|
|
2024
Q4 | $1.24M | Buy |
18,817
+2,154
| +13% | +$142K | 0.02% | 495 |
|
|
2024
Q3 | $1.17M | Buy |
16,663
+7,760
| +87% | +$545K | 0.03% | 457 |
|
|
2024
Q2 | $733K | Sell |
8,903
-124
| -1% | -$10.2K | 0.02% | 548 |
|
|
2024
Q1 | $788K | Buy |
9,027
+810
| +10% | +$70.7K | 0.02% | 492 |
|
|
2023
Q4 | $792K | Sell |
8,217
-1,855
| -18% | -$179K | 0.02% | 450 |
|
|
2023
Q3 | $891K | Sell |
10,072
-1,712
| -15% | -$151K | 0.03% | 414 |
|
|
2023
Q2 | $1.02M | Buy |
11,784
+639
| +6% | +$55.4K | 0.03% | 387 |
|
|
2023
Q1 | $1.08M | Buy |
11,145
+20
| +0.2% | +$1.95K | 0.03% | 316 |
|
|
2022
Q4 | $1.15M | Sell |
11,125
-1,487
| -12% | -$154K | 0.03% | 285 |
|
|
2022
Q3 | $1.07M | Sell |
12,612
-2,686
| -18% | -$228K | 0.04% | 260 |
|
|
2022
Q2 | $1.27M | Sell |
15,298
-4,528
| -23% | -$375K | 0.04% | 249 |
|
|
2022
Q1 | $1.53M | Sell |
19,826
-5,557
| -22% | -$429K | 0.03% | 254 |
|
|
2021
Q4 | $2.24M | Sell |
25,383
-6,364
| -20% | -$562K | 0.04% | 230 |
|
|
2021
Q3 | $2.45M | Buy |
31,747
+528
| +2% | +$40.8K | 0.06% | 211 |
|
|
2021
Q2 | $2.61M | Buy |
31,219
+3,671
| +13% | +$306K | 0.08% | 200 |
|
|
2021
Q1 | $2.08M | Buy |
27,548
+11,012
| +67% | +$831K | 0.08% | 197 |
|
|
2020
Q4 | $1.45M | Buy |
16,536
+10,504
| +174% | +$921K | 0.07% | 192 |
|
|
2020
Q3 | $459K | Buy |
6,032
+3,520
| +140% | +$268K | 0.03% | 320 |
|
|
2020
Q2 | $310K | Buy |
2,512
+1,287
| +105% | +$159K | 0.05% | 353 |
|
|
2020
Q1 | $104K | Buy |
1,225
+350
| +40% | +$29.7K | 0.06% | 256 |
|
|
2019
Q4 | $74K | Buy |
+875
| New | +$74K | 0.02% | 238 |
|